Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 10 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-10-2024-4

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 10, 2024, titled "Zydus receives tentative approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases